All News

RheumNow Podcast square

RheumNow Podcast – Modern Treatment of RA Pregnancy (6.25.2021)

Jack Cush, MD

Dr. Jack Cush reviews this week’s news and journal reports featured on RheumNow.com.

Read Article
PSA2L.jpg

Progression from Psoriasis to Psoriatic Arthritis

Jack Cush, MD

The question of whether psoriasis is a state or pre-clinical psoriatic arthritis has been addressed by several studies; with one suggesting that biologic use in psoriasis may aver the future development of psoratic arthritis (PsA).

Read Article
pso.arm_.JPG

Which patients with psoriasis are at risk to develop PsA?

Paul Studenic, MD, PhD

The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum.

Read Article
meeting.audience.3.jpg

EULAR 2021 – Day 4 Report

Jack Cush, MD

It's been nearly two weeks since EULAR 21 ended. There were several presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4, the final day of the meeting.

Read Article
artificial intelligence machine learning computer

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis

David Liew, FRACP

Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress.

Read Article
depression oh no HA

Psoriatic arthritis mortality & morbidities

Paul Studenic, MD, PhD

Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. The current study of Tillett et al (OP0231) assessed comorbidities and patient characteristics comparing psoriasis patients with or without PsA.

Read Article
RheumNow Podcast square

RheumNow Podcast - Best of EULAR 2021

Jack Cush, MD

Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.

Read Article
DAPSA PsA measure

Q-DAPSA for Measuring Disease Activity in PsA

Rachel Tate, DO

Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain comprehensive and validated.

Read Article
The FDA has informed Abbvie that their supplemental application for new indications (PsA and AS) for upadacitinib (Rinvoq) has been delayed; the FDA citing its ongoing review of tofacitinibs safety concerns stemming from the ORAL Surveillance RA study https://t.co/sSJyVtQNYu

Links:

Dr. John Cush RheumNow ( View Tweet)

Mouse model of psoriasis; 10 week exposure of western diet (high sugar & fat) induced dysbiosis and increased skin psoriasis & PsA , with increased IL-17A γδ T cells and helper type 17 cytokines. Treatment w/ Abx reduced IL-23 mediated dz. https://t.co/fTCnYiQ3wL

Links:

Dr. John Cush RheumNow ( View Tweet)

Do gender and racial disparities play a role in PsA patients? https://t.co/SrMcGOIbu4 https://t.co/QKD0VoK6fC

Links:

Dr. John Cush RheumNow ( View Tweet)
What are some predictors of PSA development in psoriasis patients? https://t.co/cPlTEJBK5U https://t.co/il6ajaVvtq

Links:

Dr. John Cush RheumNow ( View Tweet)
Which patients with psoriasis are at risk to develop PsA? The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum. https://t.co/5sj5HSnke3 https://t.co/UhRHXQwZfG

Links:

Dr. John Cush RheumNow ( View Tweet)
Ten Things to Tell Patients About Diet and Rheumatic Disease: Dr. Eric Dein ( @ejdein1 ) https://t.co/q2Mc1gLZig https://t.co/iV5JO8m5Sv

Links:

Dr. John Cush RheumNow ( View Tweet)
Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. https://t.co/zHfeaiiG93

Links:

Dr. John Cush RheumNow ( View Tweet)

Popular article alert! New GRAPPA 2021 PsO and PsA Treatment Recommendations Dr. Rachel Tate ( @uptoTate ) shares insights from abstract #OP0229 at #EULAR2021. https://t.co/AnHQGA8aKs https://t.co/9Acnzofiu4

Links:

Dr. John Cush RheumNow ( View Tweet)
How do we personalize psoriatic arthritis treatment? Dr. Robert Chao ( @doctorRBC ) discusses presentation 6937 from #EULAR2021. https://t.co/1d9IsSqr0n https://t.co/ZbHwdWimgL

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Treatment Options for PsA Patients: Dr. Paul Studenic Dr. Paul Studenic reviews highlights from three PsA abstracts - abstract op0227, abstract op0229, and abstract op0233 - presented at the virtual #EULAR2021 meeting. https://t.co/QlquUQFQOJ https://t.co/p5wBTboIpE

Links:

Dr. John Cush RheumNow ( View Tweet)
Psoriatic arthritis mortality & morbidities by Dr. Paul Studenic #EULAR2021 PsA is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. https://t.co/zHfeaiiG93 https://t.co/AoHenH6YkK

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: The PsA SpA Paradox of Choice Dr. Rachel Tate ( @uptoTate) reviews Dr. Laura Coates' presentation Personalized Treatment Strategies in Psoriatic Arthritis, given at the virtual #EULAR2021 meeting. https://t.co/Yg12SHR1MF https://t.co/UiCYDU5XGc

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×